News

A study revealed that the severity of Raynaud’s phenomenon, a common early manifestation of systemic sclerosis, is influenced significantly by ambient temperature.

New clinical trial results, presented at ESMO 2024, show that an investigational mRNA-based vaccine CVGBM is safe and well-tolerated in patient with newly diagnosed MGMT-unmethylated glioblastoma (GBM).

Researchers have confirmed that the COVID-19 mRNA vaccination is safe and beneficial for children and adults with sickle cell disease.

The ESC 2024 TIGHT-K trial found that relaxed potassium control is just as effective as tight control for preventing atrial fibrillation post-CABG surgery.

A recent study shows that post-transplant cyclophosphamide-based prophylaxis improves outcomes for hematopoietic cell transplantation patients.

A single-pill with four blood pressure drugs is more effective than a three-drug combo for resistant hypertension, per ESC Congress 2024.

A study compared the effectiveness of three immunomodulatory therapies combined with corticosteroids in preventing uveitis relapse in patients with severe Behcet’s disease.

A new study has provided new insights into the effects of haematopoietic cell transplant on pulmonary function in adults with sickle cell disease.